Care in Multiple Sclerosis (MS)

Who May Qualify: Aim 1 - - aged ≥18-29 years - diagnosis of RRMS (Fulfill international criteria for relapsing remitting (RRMS)) - 70% self-identifying as a Black, Hispanic, or poverty-impacted (up to 138% of the federal poverty level) individual,and - fluent in English or Spanish. Aim 2 - - aged ≥18-29 years - diagnosis of RRMS (Fulfill international criteria for relapsing remitting (RRMS)) - 70% self-identifying as a Black, Hispanic, or poverty impacted, and - fluent reading in English or Spanish - Pediatric onset MS (MS onset before age 18 and age at time of enrollment is 18-25) OR adult-onset MS (MS onset at age 18 or older and age at time of enrollment is 19-29) - Disease duration below 8 years Aim 3 - Aim 3 will enroll the first 20 participants from Aim 2 who meet the following criteria: - completed at least 80% of study data in the cross-sectional study/Aim 2. - a total of 70% must self-identify as Black, Hispanic, or meet criteria for poverty impacted. - interviews will be evenly split between participants with high (top quartile) and low (bottom quartile) of PROMIS-10 scores. Who Should NOT Join This Trial: - Primary or Secondary Progressive MS - Inability to consent. - MS relapse within 30 days prior to study entry - Other major neurologic or psychiatric illness Always talk to your doctor about whether this trial is right for you.